Medtronic Diabetes
From Wikipedia, the free encyclopedia
| Medtronic Diabetes Formerly Medtronic MiniMed |
|
 |
|
| Type | Division of Medtronic |
|---|---|
| Founded | Founded in the 1983, spunoff from Pacesetter Systems to form Minimed, Acquired by Medtronic, to form Medtronic Minimed, now Medtronic Diabetes |
| Headquarters | Northridge, Connecticut, USA |
| Industry | Diabetes Management, Medical Devices |
| Products | Insulin Pumps, Continuous Blood Glucose Monitoring Systems |
| Slogan | Alleviating Pain • Restoring Health • Extending Life |
| Website | [1] |
Medtronic Diabetes is the diabetes management manufacturing and sales division of Medtronic. The company was founded in the early 1980s and spunoff from Pacesetter Systems, in order to design a practical insulin pump for lifelong wear. Most devices at the time were either too large or impossible to program and extremely unreliable. The release of the lightweight, menu-driven MiniMed 500 series changed the landscape, and was a major factor in bringing pump usage to the mainstream.
Current models consist of the MiniMed Paradigm 522/722. It is the first Insulin Pump which integrates continuous glucose monitoring, allowing patients to see in real time their glucose level. As well as insulin pumps Medtronic Diabetes also makes Continuous Blood Glucose Monitoring Systems (CGMS) for use as a stand alone system or integrated into their Minimed Paradigm 522/722 series pumps. Medtronic Diabetes also makes a large range of accesories and componets for their insulin pump and CGMS products.
[edit] Re-Branding
As of March 2007 the MiniMed name has began to be absorbed into the parent company, Medtronic. Medtronic has kept the MiniMed name to brand their insulin pumps, for example: The MiniMed Paradigm 722. Medtronic frequently uses Medtronic Diabetes as the name for the divison, it is unclear to the extent the division will be integrated into Medtronic, as it still maintains its own website. Many products and marketing material still say Medtronic MiniMed, as the brand is being phased out.
